Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

ClinicalTrials.gov ID: NCT00562341

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00562341. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels, Testosterone, Estrogen and Other Serum Markers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The proposed prospective study aims to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. If PSA levels are found to rise after weight loss, interpretation of PSA levels in morbidly obese men may be improved by upward correction of the PSA level. A 'correction factor' may be proposed for the interpretation of PSA levels in obese men, toward the clinical decision regarding indication for prostate biopsy.

Study identification

NCT ID: NCT00562341
Recruitment status: Withdrawn
Study type: Observational
Phase: Not listed
Lead sponsor: Maimonides Medical Center; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Bariatric Surgery Other

Other

Eligibility (public fields only)

Age range: 20 Years to 60 Years
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 2007 (Type not available)
Primary completion: Dec 31, 2009 (Actual)
Completion: Dec 31, 2009 (Actual)
Last update posted: Aug 23, 2018

2007 – 2009

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Maimonides Medical Center	Brooklyn	New York	11219	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00562341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 23, 2018 · Synced Nov 13, 2026